NasdaqCM - Delayed Quote USD

Vincerx Pharma, Inc. (VINC)

0.0500
-0.0050
(-9.09%)
At close: 3:55:37 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
31,463
31,463
42,609
68,722
62,656
Operating Income
-31,463
-31,463
-42,609
-68,722
-62,656
Net Non Operating Interest Income Expense
472
472
1,251
664
0
Other Income Expense
917
917
1,201
5,074
23,350
Pretax Income
-30,074
-30,074
-40,157
-62,984
-39,306
Net Income Common Stockholders
-30,074
-30,074
-40,157
-62,984
-39,306
Diluted NI Available to Com Stockholders
-30,074
-30,074
-40,157
-62,984
-39,306
Basic EPS
-15.85
--
-37.72
-62.20
-45.80
Diluted EPS
-15.85
--
-37.72
-62.20
-45.80
Basic Average Shares
1,898
--
1,065
1,051.4500
858.8000
Diluted Average Shares
1,898
--
1,065
1,051.4500
858.8000
Total Operating Income as Reported
-31,463
-31,463
-42,609
-71,191
-62,656
Total Expenses
31,463
31,463
42,609
68,722
62,656
Net Income from Continuing & Discontinued Operation
-30,074
-30,074
-40,157
-62,984
-39,306
Normalized Income
-30,257
-30,257
-40,110
-66,818
-62,664
Interest Income
472
472
1,251
664
0
Net Interest Income
472
472
1,251
664
0
EBIT
-31,463
-31,463
-42,609
-68,722
-62,656
EBITDA
-30,373
-30,373
-41,694
-67,783
-62,316
Reconciled Depreciation
1,090
1,090
915
939
340
Net Income from Continuing Operation Net Minority Interest
-30,074
-30,074
-40,157
-62,984
-39,306
Total Unusual Items Excluding Goodwill
183
183
-47
3,834
23,358
Total Unusual Items
183
183
-47
3,834
23,358
Normalized EBITDA
-30,556
-30,556
-41,647
-71,617
-85,674
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 5/27/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AEON AEON Biopharma, Inc.
0.5022
+2.07%
 
XCUR Exicure, Inc.
11.40
-3.88%
 
CELUW Celularity Inc.
0.0400
+4.99%
 
ELEV Elevation Oncology, Inc.
0.3490
-3.14%
 
SLXN Silexion Therapeutics Corp
0.9702
-2.88%
 
AARD Aardvark Therapeutics, Inc.
10.14
-7.57%
 
ABP Abpro Corporation
0.2050
-2.29%
 
VTYX Ventyx Biosciences, Inc.
1.2000
-0.83%
 
ERNA Ernexa Therapeutics Inc.
0.2190
+4.29%
 
CELU Celularity Inc.
1.8700
+23.03%